share_log

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Transcode Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Marquet Magda

Transcode Therapeutics | 4：持股變動聲明-董事 Marquet Magda
美股sec公告 ·  06/19 04:21
牛牛AI助理已提取核心訊息
Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
Transcode Therapeutics, Inc. [RNAZ] has reported a transaction involving Marquet Magda, a reporting person associated with the company. The transaction took place on 06/14/2024. However, the details regarding the relationship of Marquet Magda to the issuer, the nature of the transaction, the number of shares involved, and the transaction price were not disclosed in the announcement. Without this information, the impact of the transaction on Marquet Magda's holdings and the total value of shares post-transaction remain unclear.
治療轉碼公司[RNAZ]報告了與該公司有關的報告人Marquet Magda的一項交易。交易發生在2024年06月14日。然而，公告中未披露Marquet Magda與發行人的關係、交易的性質、涉及的股份數量和交易價格等細節。沒有這些信息，交易對Marquet Magda持股以及交易後的股票總價值的影響仍不清楚。
治療轉碼公司[RNAZ]報告了與該公司有關的報告人Marquet Magda的一項交易。交易發生在2024年06月14日。然而，公告中未披露Marquet Magda與發行人的關係、交易的性質、涉及的股份數量和交易價格等細節。沒有這些信息，交易對Marquet Magda持股以及交易後的股票總價值的影響仍不清楚。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。